Tel, Burçin Meryem AtakKahveci, GizemDuman, Tuba TaslamacıoğluKurtkulağı, ÖzgeŞentürk, HilalAkın, HavvaAktaş, Gülali2023-05-182023-05-182022Tel, B. M. A., Kahveci, G., Duman, T. T., Kurtkulagi, Ö., Bilgin, S., Senturk, H., ... & Aktas, G. (2022). A relapsing immune thrombocytopenia case in a patient following COVID-19 vaccination. Journal of Health and Allied Sciences NU, 12(01), 96-97.2582-42872582-4953http://dx.doi.org/10.1055/s-0041-1731915https://hdl.handle.net/20.500.12491/10915There are several vaccines developed against COVID-19 infection. Inactivated viral vaccines are usually well tolerated. We aimed to present a relapsing immune thrombocytopenia case following inactive COVID-19 vaccine. Here we report a case of relapsing immune thrombocytopenia following inactivated viral vaccine against COVID-19 in a 60-year-old woman with a history of immune thrombocytopenia. The patient responded well to dexamethasone treatment and was discharged from the hospital with full recovery. We suggest that physicians seek the history of a recent inactivate COVID-19 vaccine shot in patients with immune thrombocytopenia.eninfo:eu-repo/semantics/openAccessCOVID-19Immune ThrombocytopeniaInactivated Viral VaccineArticle10.1055/s-0041-17319151219697WOS:000678064300004N/A